Live
FierceBiotechSanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic diseasePharmaVoiceBacked by Sanofi and Roche, Orano Med chases radiopharma leadershipLabiotech8 of the most expensive drugs in biopharma: Unraveling the costliest medicationsEndpoints NewsPost-Hoc Live: Are the China hawks winning?FierceBiotechFor biopharma manufacturing at speed and scale, the future is flexibleBioPharma DiveAbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugsFierceBiotechDefinium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO saysFierceBiotechHelmed by Sanofi vet, Bionyara emerges with $165M and three licensed I&I assetsEndpoints NewsRegenxbio to resubmit Hunter syndrome gene therapy without new studyEndpoints NewsDefinium reports Phase 3 hit for LSD drug in severe form of depressionEndpoints NewsAbbVie makes $10.9B move for Apogee's long-acting I&I drug candidatesEndpoints NewsA Sanofi alum looks to take on the TL1A field with $165M for Bionyra

Archive

Latest Oldest Clear
Total 517
Page 20 / 29
Query --